Clinical Trial Update: Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study [Phase 3]

View source ↗

Summary

The EVOLVE CLL/SLL study is a Phase 3 clinical trial sponsored by the National Cancer Institute to evaluate early treatment in patients with high-risk chronic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | Status: RECRUITING